Stegent Equity Advisors Inc. Purchases 72 Shares of CME Group Inc. (NASDAQ:CME)

Stegent Equity Advisors Inc. grew its holdings in CME Group Inc. (NASDAQ:CME) by 5.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,471 shares of the financial services provider’s stock after acquiring an additional 72 shares during the quarter. Stegent Equity Advisors Inc.’s holdings in CME Group were worth $325,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CME. Salomon & Ludwin LLC acquired a new stake in shares of CME Group in the 1st quarter valued at about $28,000. Y.D. More Investments Ltd bought a new stake in CME Group in the 2nd quarter valued at approximately $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its position in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares during the last quarter. McClarren Financial Advisors Inc. grew its stake in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares in the last quarter. Finally, Asset Dedication LLC raised its holdings in shares of CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the subject of several recent research reports. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Piper Sandler increased their price objective on shares of CME Group from $225.00 to $240.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 8th. Morgan Stanley lifted their target price on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday. Citigroup increased their price target on CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Finally, Oppenheimer boosted their price target on CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $220.07.

CME Group Stock Performance

NASDAQ CME traded up $1.09 on Friday, reaching $228.32. The stock had a trading volume of 1,203,010 shares, compared to its average volume of 1,941,867. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $82.21 billion, a P/E ratio of 25.97, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The firm has a fifty day moving average of $216.92 and a two-hundred day moving average of $208.34. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.12.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. CME Group’s revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.30 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.